140 related articles for article (PubMed ID: 6390235)
1. [Plasmapheresis and immunosuppressive drugs in the treatment of multiple sclerosis].
Cendrowski W
Neurol Neurochir Pol; 1984; 18(3):259-62. PubMed ID: 6390235
[No Abstract] [Full Text] [Related]
2. [Immunosuppressive treatment of multiple sclerosis (review of the literature].
Neretin VIa; Kir'iakov VA; Sapfirova VA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):119-26. PubMed ID: 2160156
[No Abstract] [Full Text] [Related]
3. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Hauser SL; Fosburg M; Kevy S; Weiner HL
Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
[TBL] [Abstract][Full Text] [Related]
4. [New therapeutic possibilities for disseminated sclerosis?].
Wanscher B; Sørensen PS
Ugeskr Laeger; 1994 Oct; 156(43):6353-8. PubMed ID: 7810008
[TBL] [Abstract][Full Text] [Related]
5. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
Schönbeck S; Hohlfeld R
Nervenarzt; 1992 Feb; 63(2):116-9. PubMed ID: 1314334
[No Abstract] [Full Text] [Related]
6. Plasmapheresis in multiple sclerosis: preliminary findings.
Dau PC; Petajan JH; Johnson KP; Panitch HS; Bornstein MB
Neurology; 1980 Oct; 30(10):1023-8. PubMed ID: 6448360
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapeutics of multiple sclerosis.
Durelli L
Acta Neurol (Napoli); 1991 Oct; 13(5):467-75. PubMed ID: 1723242
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of severe exophthalmia using intensive plasma exchange].
Glinoer D
Rev Med Brux; 1986 Jun; 7(6):379-80. PubMed ID: 3755543
[No Abstract] [Full Text] [Related]
9. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
[TBL] [Abstract][Full Text] [Related]
10. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
[TBL] [Abstract][Full Text] [Related]
11. Plasmapheresis in multiple sclerosis: preliminary study.
Weiner HL; Dawson DM
Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
Lhermitte F; Marteau R; de Saxcé H
Rev Neurol (Paris); 1987; 143(2):98-107. PubMed ID: 3299618
[TBL] [Abstract][Full Text] [Related]
13. Successful immunoadsorption with membrane plasmapheresis for multiple sclerosis.
Hosokawa S; Oyamaguchi A; Yoshida O
ASAIO Trans; 1989; 35(3):576-7. PubMed ID: 2688722
[TBL] [Abstract][Full Text] [Related]
14. [The problem and value of therapy in multiple sclerosis].
Hitzschke B; Meyer-Rienecker HJ; Buddenhagen F; Richter M
Psychiatr Neurol Med Psychol (Leipz); 1988 Oct; 40(10):598-608. PubMed ID: 3237866
[TBL] [Abstract][Full Text] [Related]
15. A closer look at plasmapheresis in multiple sclerosis: the cons.
Tindall R
Neurology; 1988 Jul; 38(7 Suppl 2):53-6. PubMed ID: 3290716
[TBL] [Abstract][Full Text] [Related]
16. Recurrent cold hemagglutinin disease following allogeneic bone marrow transplantation successfully treated with plasmapheresis, corticosteroid and cyclophosphamide.
Azuma E; Nishihara H; Hanada M; Nagai M; Hiratake S; Komada Y; Sakurai M
Bone Marrow Transplant; 1996 Jul; 18(1):243-6. PubMed ID: 8832028
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis.
Uchida A; Maida EM; Lenzhofer R; Micksche M
Immunobiology; 1982 Feb; 160(5):392-402. PubMed ID: 6175561
[TBL] [Abstract][Full Text] [Related]
18. Childhood multiple sclerosis treated with plasmapheresis.
Takahashi I; Sawaishi Y; Takeda O; Enoki M; Takada G
Pediatr Neurol; 1997 Jul; 17(1):83-7. PubMed ID: 9308985
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive therapy for chronic liver disease.
Murray-Lyon IM
J R Coll Physicians Lond; 1973 Oct; 8(1):37-44. PubMed ID: 4583701
[No Abstract] [Full Text] [Related]
20. Azathioprine in multiple sclerosis: the cons.
Silberberg DH
Neurology; 1988 Jul; 38(7 Suppl 2):24-7. PubMed ID: 3290710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
